64 results about "Dimethyl Sulphone" patented technology

The invention discloses a glucosamine chewable tablet used for relieving and preventing osteoarthritis and a preparation method thereof. The glucosamine chewable tablet comprises active ingredients and auxiliary materials, wherein the active ingredients comprise glucosamine, vitamin C and dimethyl sulfone, the glucosamine is glucosamine sulfate or glucosamine hydrochloride or glucosamine phosphateor mixture of the glucosamine sulfate and the glucosamine hydrochloride and the glucosamine phosphate; and the auxiliary materials comprise excipient, bonding agent, flavouring agent and lubricant. The glucosamine chewable table is slowly disintegrated and released without entering the gastrointestinal tract through the chewing and is absorbed through the increment of the taking number, therefore, the medicine effect is improved, and the discomfort of a patient with poor gastrointestinal tract function, caused by a deglutible tablet accelerating the gastrointestine load, is reduced. The glucosamine chewable tablet has the advantages of good mouth feel, high bioavailability, more convenient taking, convenient carrying and the like, and can fully play a role of the product.

The invention discloses a method for preparing dimethyl sulfone from dimethyl sulfoxide. The method comprises the following step: contacting dimethyl sulfoxide and an oxidant under the oxidizing reaction conditions. The method is characterized in that the oxidant is ozone-containing gas. According to the method, the selectivity of dimethyl sulfone is high, and especially the effective utilization rate of ozone is greatly improved in the presence of a titanium-containing catalyst.

The invention provides a nutritional composition capable of improving motion system functions of the elderly people and a preparation method thereof. The nutritional composition capable of improving the motion system functions of the elderly people is composed of the following ingredients in parts by weight: 10-15 parts of whey protein, 0.5-1 part of whey protein peptides, 0.5-1 part of wheat protein peptides, 2-10 parts of collagen peptides, 0.05-0.15 part of casein phospho peptides, 2-5 parts of leucine, 0.5-3 parts of beta-hydroxy-beta-butyric acid, 0.5-1 part of calcium, 0.2-0.5 part of magnesium, 5-20 parts of chicken breast cartilage meal, 0.1-0.5 part of chitosan oligosaccharide, 0.5-2 parts of dimethyl sulfone, 0.1-1 part of curcumin, and 0.02-0.15 part of a vitamin mixture. The nutritional composition is capable of supplementing nutrients according to functional state of the motion system of the elderly people in a targeted way on basis of system nutrition theories. And thus, overall health of the motion system of the elderly people can be promoted under synergistic actions of the functional effects of the nutrients.

The invention belongs to the technical field of veterinary drug preparations, and discloses a compound spray film agent for cows, which is made of the following components in parts by weight: 1-5 parts of povidone-iodine, 0.1-2 parts of clove oil, two 2-8 parts of methyl sulfone, 3-10 parts of film-forming agent, 0.5-2 parts of thickener, 0.5-2 parts of humectant, 0.5-2.5 parts of transdermal absorption accelerator, 70-90 parts of solvent; the solvent It is a mixture of alcoholic solvents and aqueous solvents. The compound spray film agent of the present invention uses povidone iodine, clove oil, borneol / menthol, and dimethyl sulfone as the composite components of the principal agent, and dimethyl sulfone is applied to the film spray agent for cow mastitis for the first time to improve poly Povidone iodine and clove essential oil’s antibacterial and disinfection ability can promote the healing of dairy cow udder wounds, and solve the problem that traditional spraying agents only use povidone iodine single preparation and can only prevent dairy cow mastitis but cannot treat it; compared with other dairy cow mastitis The preparation for external use is evenly coated, the film-forming speed is fast, there is no sagging or dripping phenomenon, the effect of promoting wound healing is obvious, and the healing rate is high.

The invention provides a device for producing dimethyl sulfone by double-tower rectification. The feed pipe is connected to the middle part of the mother rectification tower, the bottom of the mother rectification tower is connected to the reboiler, the reboiler is connected to the bottom of the sub-rectification tower, and the sub-rectification tower is connected to the bottom of the sub-rectification tower. The top of the distillation tower is connected to the atomized crystallizer, the atomized crystallizer is connected to the first storage tank, the atomized crystallizer and the bottom of the storage tank are respectively connected to the product area through pipelines, and connected to the upper part of the sub-distillation tower. The process includes opening the reboiler, evacuating the mother rectification tower and the sub-distillation tower, feeding the fraction to be separated into the mother rectification tower through the feed port, and extracting a large amount of dimethyl sulfone from the top of the sub-rectification tower. The top fraction of the sub-distillation tower is granulated and screened by an atomization crystallizer to obtain dimethyl sulfone product. In this process scheme, the mode of rectification and separation under vacuum state breaks the traditional long-term low-temperature crystallization and centrifugal separation mode, and greatly improves the purity and quality level of the product; the selected rectification equipment is double-tower rectification, which is shared by both towers Reboiler saves energy consumption.

The present invention relates to sterilized compositions comprising at least one hyaluronic acid and magnesium ascorbyl phosphate, in particular to sterilized compositions comprising at least one hyaluronic acid or a biological Pharmaceutically acceptable salts and magnesium ascorbyl phosphate, the mass ratio [HA] / [MAP] of the content of hyaluronic acid or one of its salts [HA] to the content of magnesium ascorbyl phosphate [MAP] is greater than or equal to 1, ascorbic acid The content of magnesium phosphate is from 0.001% to 1% by weight relative to the total weight of the composition, wherein the elastic component G' is maintained or increased after sterilization and is from 5 to 400 Pa. The present invention also relates to a composition according to the invention further comprising dimethyl sulfone, a process for its preparation and its use.